As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global ...

Fundamental and Computational Sciences Directorate, Pacific Northwest National Laboratory, Richland, Washington 99352, and University of Michigan, School of Medicine, Ann Arbor, Michigan 48109 * To ...

The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury ...

This paper gives a statistical analysis of the results of various liver function tests on a group of patients with congestive heart failure. The analysis includes comparisons based on etiology, type ...